DOCSLIB.ORG

Liothyronine Sodium(BANM, Rinnm) Potassium Perchlorate

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Liothyronine Sodium(BANM, Rinnm) Potassium Perchlorate 2174 Thyroid and Antithyroid Drugs with methodological limitations. However, a controlled trial of In myxoedema coma liothyronine sodium may be liothyronine with paroxetine could not confirm any advantage of given intravenously in a dose of 5 to 20 micrograms by 3 O additive therapy. slow intravenous injection, repeated as necessary, usu- 1. Aronson R, et al. Triiodothyronine augmentation in the treat- HO I ally at intervals of 12 hours; the minimum interval be- ment of refractory depression: a meta-analysis. Arch Gen Psychi- OH atry 1996; 53: 842–8. tween doses is 4 hours. An alternative regimen advo- 2. Altshuler LL, et al. Does thyroid supplementation accelerate tri- NH2 cates an initial dose of 50 micrograms intravenously cyclic antidepressant response? A review and meta-analysis of I O the literature. Am J Psychiatry 2001; 158: 1617–22. followed by further injections of 25 micrograms every 3. Appelhof BC, et al. Triiodothyronine addition to paroxetine in I 8 hours until improvement occurs; the dosage may the treatment of major depressive disorder. J Clin Endocrinol then be reduced to 25 micrograms intravenously twice Metab 2004; 89: 6271–6. (liothyronine) daily. Obesity. Thyroid drugs have been tried in the treatment of obes- Liothyronine has also been given in the diagnosis of ity (p.2149) in euthyroid patients, but they produce only tempo- NOTE. The abbreviation T3 is often used for endogenous tri-io- hyperthyroidism in adults. Failure to suppress the up- rary weight loss, mainly of lean body-mass, and can produce se- dothyronine in medical and biochemical reports. Liotrix is USAN rious adverse effects, especially cardiac complications.1 for a mixture of liothyronine sodium with levothyroxine sodium. take of radio-iodine after several days of receiving lio- Hypothyroidism has also been reported2 when these drugs were Pharmacopoeias. In Eur. (see p.vii), Jpn, and US. thyronine sodium suggests a diagnosis of hyperthy- withdrawn from previously euthyroid patients being treated for Ph. Eur. 6.2 (Liothyronine Sodium). A white or almost white or roidism. simple obesity. Levothyroxine appears to have been abused by slightly coloured powder. Practically insoluble in water; slightly Liothyronine hydrochloride has also been used. some athletes to promote weight loss.3 soluble in alcohol. It dissolves in dilute solutions of alkali hy- 1. Rivlin RS. Therapy of obesity with hormones. N Engl J Med droxides. Store at 2° to 8° in airtight containers. Protect from Preparations 1975; 292: 26–9. light. BP 2008: Liothyronine Tablets; 2. Dornhorst A, et al. Possible iatrogenic hypothyroidism. Lancet USP 31 (Liothyronine Sodium). A light tan, odourless, crystal- USP 31: Liothyronine Sodium Tablets; Liotrix Tablets. 1981; i: 52. line powder. Very slightly soluble in water; slightly soluble in al- Proprietary Preparations (details are given in Part 3) 3. MacAuley D. Drugs in sport. BMJ 1996; 313: 211–15. cohol; practically insoluble in most other organic solvents. Store Austral.: Te r t r ox i n ; Braz.: Cynomel†; Canad.: Cytomel; Cz.: Tertroxin†; in airtight containers. Fr.: Cynomel; Ger.: Thybon; Thyrotardin N; Gr.: Cynomel†; T-3; Ital.: Dis- Urticaria. There is some suggestion that chronic urticaria pon†; Ti-Tre; Mex.: Cynomel; Liotrex; Triyotex; Neth.: Cytomel; NZ: Ter- (p.1584) may be associated with thyroid autoimmunity and that troxin; Port.: Neo-Tiroimade; S.Afr.: Ter troxin; Thai.: Tertroxin†; Turk.: treatment with thyroid hormones may result in clinical remis- Adverse Effects, Treatment, and Precau- Tiromel; UK: Tertroxin†; Triiodothyronine Injection; USA: Cytomel; Trio- sion.1 In one study, a nine-year-old boy was successfully treated tions stat; Venez.: Te r t r ox i n† . for chronic urticaria with levothyroxine therapy at doses of 50 to As for Levothyroxine Sodium, p.2171. Multi-ingredient: Arg.: Eutroid; Levotrin; Tresite F; Austria: Combithy- 2 rex; Novothyral; Prothyrid; Belg.: Novothyral; Braz.: Tyroplus†; Chile: 100 micrograms daily. The authors advised screening for thy- Novothyral; Cz.: Novothyral†; Thyreotom; Fr.: Euthyral; Ger.: NeyNormin roid function and anti-thyroid microsomal antibodies in cases of Interactions N (Revitorgan-Dilutionen N Nr 65)†; NeyTumorin N (Revitorgan-Dilutio- chronic urticaria as these patients may benefit from thyroid hor- nen N Nr 66)†; Novothyral; Prothyrid; Thyreotom†; Gr.: Dithyron; Ital.: mone therapy. A small investigative study concluded that treat- As for Levothyroxine Sodium, p.2172. Tiroide Amsa; Mex.: Cynoplus; Novotiral; Proloid S†; Redotex; Pol.: Novothyral; Rus.: Novothyral (Новотирал); Thyreocomb (Тиреокомб); ment with levothyroxine sodium (in hypothyroid patients) or Thyreotom (Тиреотом); S.Afr.: Diotroxin; Switz.: Novothyral; Turk.: Biti- antithyroid drugs (in patients with Graves’ disease) is of benefit Pharmacokinetics ron; USA: Thyrolar. in patients with severe chronic urticaria associated with thyroid Liothyronine is readily and almost completely ab- autoimmunity.3 sorbed from the gastrointestinal tract. Once in the cir- 1. Rumbyrt JS, et al. Resolution of chronic urticaria in patients with culation, liothyronine binds principally to thyroxine- thyroid autoimmunity. J Allergy Clin Immunol 1995; 96: 901–5. binding globulin (TBG), although less strongly than Potassium Perchlorate 2. Dreyfus DH, et al. Steroid-resistant chronic urticaria associated with anti-thyroid microsomal antibodies in a nine-year-old boy. levothyroxine; some is also bound to thyroxine-bind- Chloristan draselný; Kalii perchloras; Kalio perchloratas; Ka- J Pediatr 1996; 128: 576–8. ing pre-albumin (TBPA) or to albumin. Liothyronine liumperkloraatti; Kaliumperklorat; Kálium-perklorát; Perclorato 3. Gaig P, et al. Successful treatment of chronic idiopathic urticaria has a plasma half-life in euthyroidism of about 1 to 2 potásico; Potassium, perchlorate de. associated with thyroid autoimmunity J Investig Allergol Clin KClO = 138.5. days; the half-life is prolonged in hypothyroidism and 4 Immunol 2000; 10: 342–5. CAS — 7778-74-7. reduced in hyperthyroidism. Preparations ATC — H03BC01. Liothyronine is metabolised by deiodination to inac- ATC Vet — QH03BC01. BP 2008: Levothyroxine Tablets; USP 31: Levothyroxine Sodium Tablets; Liotrix Tablets. tive di-iodothyronine and mono-iodothyronine. Iodine released by deiodination is largely reused within the Proprietary Preparations (details are given in Part 3) thyroid cells. Further metabolites result from deamina- K+ Arg.: Euthyrox; Juno†; T4; Austral.: Eutroxsig; Oroxine; Austria: Euthyrox; O- Neothyron; Thyrex; Belg.: Elthyrone; Euthyrox; Thyrax; Braz.: Euthyrox; tion and decarboxylation to tiratricol (triac). Puran T4; Synthroid; Tetroid; Tiroidin; Canad.: Eltroxin; Euthyrox; Syn- O Cl O throid; Chile: Esaldox; Eutirox; Cz.: Eltroxin; Euthyrox; Letrox; Thyrax†; Uses and Administration Denm.: Eltroxin; Fr.: Levothyrox; Ger.: Berlthyrox; Eferox; Euthyrox; L- O Thyrox; Lixin; Thevier; Gr.: Levothroid; T-4; Thyro-4; Thyrohormone; Liothyronine is a thyroid hormone (see p.2165). It is Hong Kong: Eltroxin; Hung.: Euthyrox; Letrox; India: Eltroxin; Indon.: Euthyrox; Thyrax; Irl.: Eltroxin; Israel: Eltroxin; Ital.: Eutirox; Tiracrin; Ti- used in the treatment of hypothyroidism (p.2167), and Pharmacopoeias. In Eur. (see p.vii) and US. rosint; Jpn: Thyradin-S; Malaysia: Oroxine; Mex.: Abutiroi; Cynocuatro; is believed to be more active than levothyroxine Ph. Eur. 6.2 (Potassium Perchlorate). A white or almost white Daltroid†; Eutirox; Sintrocid†; Tiroidine; Neth.: Eltroxin; Euthyrox; Thyrax; Norw.: Levaxin; NZ: Eltroxin; Philipp.: Eltroxin; Euthyrox; Thyrax; Thyro- (p.2173). The onset of action of liothyronine is rapid, crystalline powder or colourless crystals. Sparingly soluble in hex; Pol.: Eferox; Eltroxin; Euthyrox; Letrox; Port.: Eutirox; Letequatro; developing within a few hours, and therefore it tends to water; practically insoluble in alcohol. Letter; Thyrax; Rus.: Bagothyrox (Баготирокс); Euthyrox (Эутирокс); be used in circumstances where this, and its short dura- USP 31 (Potassium Perchlorate). pH of a 0.1M solution in water S.Afr.: Eltroxin; Singapore: Eltroxin; Euthyrox; Oroxine; Spain: Dexnon; is between 5.0 and 6.5. Eutirox; Levothroid; Swed.: Euthyrox; Levaxin; Switz.: Eltroxine; Euthyrox; tion of action, are useful, particularly in hypothyroid Thai.: Elthyro; Eltroxin; Euthyrox; Pondtroxin; Thyrosit; Turk.: Levotiron; Te fo r ; UK: Eltroxin; Evotrox; USA: Levothroid; Levoxyl; Novothyrox; Syn- (myxoedema) coma. Sodium Perchlorate throid; Unithroid; Venez.: Euthyrox; Thyrax. With regular dosing the peak therapeutic effect is usu- Perclorato sódico; Sodu nadchloran. Multi-ingredient: Arg.: Eutroid; Levotrin; Austria: Combithyrex; Jodthy- ally achieved after 3 days; on withdrawal its effects rox; Novothyral; Prothyrid; Belg.: Novothyral; Braz.: Tyroplus†; Chile: NaClO4 = 122.4. Novothyral; Cz.: Jodthyrox; Novothyral†; Thyreotom; Fr.: Euthyral; Ger.: may persist for 1 to 3 days. CAS — 7601-89-0 (anhydrous sodium perchlorate); 7791- Eferox Jod; Jodthyrox; L-Thyrox Jod; Novothyral; Prothyrid; Thyreocomb 07-3 (sodium perchlorate monohydrate). N†; Thyreotom†; Thyronajod; Gr.: Dithyron; Ital.: Dermocinetic; Somato- The dose of liothyronine should be individualised on line; Tiroide Amsa; Mex.: Cynoplus; Novotiral; Proloid S†; Pol.: Jodthyrox; the basis of clinical response and biochemical tests and Novothyral; Rus.: Jodthyrox (Йодтирокс); Novothyral (Новотирал); Thy- should be monitored regularly. Although liothyronine Na+ reocomb (Тиреокомб); Thyreotom (Тиреотом);
Load more

Recommended publications
  • Physician Perchlorate Fact Sheet
    Physician Fact Sheet PERCHLORATE Environmental Epidemiology and Toxicology Division HIGHLIGHTS: Perchlorate competitively inhibits the uptake of iodide by the thyroid gland potentially affecting thyroid function. Pregnant women and their developing fetus may be more susceptible to the effects of perchlorate because of the stress that pregnancy places on the thyroid gland. Disruption of thyroid function could put pregnant women at greater risk for pregnancy-related complications such as preeclampsia, placental abruption, and low birth weight infants. An adequate iodine intake may negate the potential effects. Exposure levels that affect thyroid function have not been well demonstrated in humans. Currently, a National Primary Drinking Water Regulation for perchlorate does not exist. For more information, call the Texas Department of Health Environmental Epidemiology and Toxicology Division at (800)588-1248. What is Perchlorate? How does perchlorate get into the body? -1 Perchlorate (ClO4 ) is the most oxygenated member of Drinking water contaminated with perchlorate is the a series of compounds made up of chlorine and most likely way that perchlorate can get into the body. oxygen. It can form an acid or a salt in combination Perchlorate is not well absorbed through the skin. with a hydrogen ion (H+) or another cation such as sodium, potassium, or ammonium ion. Perchlorate What health effects are associated with salts, which have been widely used as an oxidizer in perchlorate? solid propellants for rockets and missiles since the mid- 1940s, have a finite shelf-life and must periodically be Perchlorate competitively inhibits the uptake of iodide replaced. As a result, large volumes of perchlorate by the thyroid gland through its effect on a transport have been disposed of since the 1950s.
    [Show full text]
  • Liothyronine Sodium(BANM, Rinnm) Potassium Perchlorate
    2174 Thyroid and Antithyroid Drugs with methodological limitations. However, a controlled trial of In myxoedema coma liothyronine sodium may be liothyronine with paroxetine could not confirm any advantage of given intravenously in a dose of 5 to 20 micrograms by 3 O additive therapy. slow intravenous injection, repeated as necessary, usu- 1. Aronson R, et al. Triiodothyronine augmentation in the treat- HO I ally at intervals of 12 hours; the minimum interval be- ment of refractory depression: a meta-analysis. Arch Gen Psychi- OH atry 1996; 53: 842–8. tween doses is 4 hours. An alternative regimen advo- 2. Altshuler LL, et al. Does thyroid supplementation accelerate tri- NH2 cates an initial dose of 50 micrograms intravenously cyclic antidepressant response? A review and meta-analysis of I O the literature. Am J Psychiatry 2001; 158: 1617–22. followed by further injections of 25 micrograms every 3. Appelhof BC, et al. Triiodothyronine addition to paroxetine in I 8 hours until improvement occurs; the dosage may the treatment of major depressive disorder. J Clin Endocrinol then be reduced to 25 micrograms intravenously twice Metab 2004; 89: 6271–6. (liothyronine) daily. Obesity. Thyroid drugs have been tried in the treatment of obes- Liothyronine has also been given in the diagnosis of ity (p.2149) in euthyroid patients, but they produce only tempo- NOTE. The abbreviation T3 is often used for endogenous tri-io- hyperthyroidism in adults. Failure to suppress the up- rary weight loss, mainly of lean body-mass, and can produce se- dothyronine in medical and biochemical reports. Liotrix is USAN rious adverse effects, especially cardiac complications.1 for a mixture of liothyronine sodium with levothyroxine sodium.
    [Show full text]
  • Fate of Sodium Pertechnetate-Technetium-99M
    JOURNAL OF NUCLEAR MEDICINE 8:50-59, 1967 Fate of Sodium Pertechnetate-Technetium-99m Dr. Muhammad Abdel Razzak, M.D.,1 Dr. Mahmoud Naguib, Ph.D.,2 and Dr. Mohamed El-Garhy, Ph.D.3 Cairo, Egypt Technetium-99m is a low-energy, short half-life iostope that has been recently introduced into clinical use. It is available as the daughter of °9Mowhich is re covered as a fission product or produced by neutron bombardement of molyb denum-98. The aim of the present work is to study the fate of sodium pertechnetate 9OmTc and to find out any difference in its distribution that might be caused by variation in the method of preparation of the parent nuclide, molybdenum-99. MATERIALS & METHODS The distribution of radioactive sodium pertechnetate milked from 99Mo that was obtained as a fission product (supplied by Isocommerz, D.D.R.) was studied in 36 white mice, weighing between 150 and 250 gm each. Normal isotonic saline was used for elution of the pertechnetate from the radionuclide generator. The experimental animals were divided into four equal groups depending on the route of administration of the radioactive material, whether intraperitoneal, in tramuscular, subcutaneous or oral. Every group was further subdivided into three equal subgroups, in order to study the effect of time on the distribution of the pertechnetate. Thus, the duration between administration of the radio-pharma ceutical and sacrificing the animals was fixed at 30, 60 and 120 minutes for the three subgroups respectively. Then the animals were dissected and the different organs taken out.Radioactivityin an accuratelyweighed specimen from each organ was estimated in a scintillation well detector equipped with one-inch sodium iodide thallium activated crystal.
    [Show full text]
  • Package Insert TECHNETIUM Tc99m GENERATOR for the Production of Sodium Pertechnetate Tc99m Injection Diagnostic Radiopharmaceuti
    NDA 17693/S-025 Page 3 Package Insert TECHNETIUM Tc99m GENERATOR For the Production of Sodium Pertechnetate Tc99m Injection Diagnostic Radiopharmaceutical For intravenous use only Rx ONLY DESCRIPTION The technetium Tc99m generator is prepared with fission-produced molybdenum Mo99 adsorbed on alumina in a lead-shielded column and provides a means for obtaining sterile pyrogen-free solutions of sodium pertechnetate Tc99m injection in sodium chloride. The eluate should be crystal clear. With a pH of 4.5-7.5, hydrochloric acid and/or sodium hydroxide may have been used for Mo99 solution pH adjustment. Over the life of the generator, each elution will provide a yield of > 80% of the theoretical amount of technetium Tc99m available from the molybdenum Mo99 on the generator column. Each eluate of the generator should not contain more than 0.0056 MBq (0.15 µCi) of molybdenum Mo99 per 37 MBq, (1 mCi) of technetium Tc99m per administered dose at the time of administration, and not more than 10 µg of aluminum per mL of the generator eluate, both of which must be determined by the user before administration. Since the eluate does not contain an antimicrobial agent, it should not be used after twelve hours from the time of generator elution. PHYSICAL CHARACTERISTICS Technetium Tc99m decays by an isomeric transition with a physical half-life of 6.02 hours. The principal photon that is useful for detection and imaging studies is listed in Table 1. Table 1. Principal Radiation Emission Data1 Radiation Mean %/Disintegration Mean Energy (keV) Gamma-2 89.07 140.5 1Kocher, David C., “Radioactive Decay Data Tables,” DOE/TIC-11026, p.
    [Show full text]
  • Common Thyroid Disorders
    9/7/17 Common Louie Riesch MSN, MPH, RN, ACNS-BC, CDE Thyroid Texas Diabetes and Endocrinology Disorders Anatomy of the Thyroid Gland Hypothalamic-Pituitary-Thyroid Axis Physiology Hypothalamus TRH • TSH reflects tissue thyroid – hormone actions • TSH as an index of Pituitary therapeutic success and – potential toxicity TSH T4 Target Tissues T3 Heart Thyroid Gland Liver T4 T3 TR Bone T4 è T3 Liver CNS 1 9/7/17 Production of T4 and T3 Ê T4 is the primary secretory product of the thyroid gland, which is the only source of T4 Ê The thyroid secretes approximately 100 nmol of T4 per day Ê T3 is derived from 2 processes Ê The total daily production rate of T3 is about 15-30 µg Ê About 80% of circulating T3 comes from deiodination of T4 in peripheral tissues Ê Largely liver and kidneys Ê About 20% comes from direct thyroid secretion Free Hormone Concept Ê Only unbound (free) hormone has metabolic activity and physiologic effects Ê Total hormone concentration Ê Normally is kept proportional to the concentration of carrier proteins Ê Is kept appropriate to maintain a constant free hormone level 2 9/7/17 Drugs and Conditions That Increase Serum T4 and T3 Levels by Increasing TBG Drugs that increase TBG Conditions that increase TBG Ê Oral contraceptives and other Ê Pregnancy sources of estrogen Ê Infectious/chronic active Ê Methadone hepatitis Ê Clofibrate Ê HIV infection Ê 5-Fluorouracil Ê Biliary cirrhosis Ê Heroin Ê Acute intermittent porphyria Ê Tamoxifen Ê Genetic factors Evaluate for thyroid disease Ê All >35 years of age, every 5 years Ê
    [Show full text]
  • Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
    TITLE 16. CRIMES AND OFFENSES CHAPTER 13. CONTROLLED SUBSTANCES ARTICLE 1. GENERAL PROVISIONS § 16-13-1. Drug related objects (a) As used in this Code section, the term: (1) "Controlled substance" shall have the same meaning as defined in Article 2 of this chapter, relating to controlled substances. For the purposes of this Code section, the term "controlled substance" shall include marijuana as defined by paragraph (16) of Code Section 16-13-21. (2) "Dangerous drug" shall have the same meaning as defined in Article 3 of this chapter, relating to dangerous drugs. (3) "Drug related object" means any machine, instrument, tool, equipment, contrivance, or device which an average person would reasonably conclude is intended to be used for one or more of the following purposes: (A) To introduce into the human body any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (B) To enhance the effect on the human body of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; (C) To conceal any quantity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state; or (D) To test the strength, effectiveness, or purity of any dangerous drug or controlled substance under circumstances in violation of the laws of this state. (4) "Knowingly" means having general knowledge that a machine, instrument, tool, item of equipment, contrivance, or device is a drug related object or having reasonable grounds to believe that any such object is or may, to an average person, appear to be a drug related object.
    [Show full text]
  • IRENAT 300 Mg/Ml, Solution Buvable En Gouttes
    1. NAME OF THE MEDICINAL PRODUCT Irenat Drops 300 mg sodium perchlorate, oral drops Sodium perchlorate monohydrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml solution (approximately 15 drops) contains 344.2 mg sodium perchlorate monohydrate (equivalent to 300 mg sodium perchlorate) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral drops 4. CLINICAL PARTICULARS 4.1 Therapeutic indications For the treatment of hyperthyroidism, for thyroid blockade in the context of radionuclide studies of other organs using radioactively labelled iodine or of immunoscintigraphy to detect tumours using antibodies labelled with radioiodine. For the detection of a congenital iodine organification defect (perchlorate discharge test). 4.2 Posology and method of administration Posology Adults receive 4-5 x 10 Irenat drops daily (equivalent to 800-1000 mg sodium perchlorate) or, exceptionally, 5 x 15 Irenat drops daily (equivalent to 1500 mg sodium perchlorate) as an initial dose for the first 1-2 weeks. The mean maintenance dose is 4 x 5 Irenat drops (equivalent to 400 mg sodium perchlorate) per day. Children between the ages of 6 and 14 are treated throughout with a dose of 3-6 x 1 or 4-6 x 2 Irenat drops (equivalent to 60-240 mg sodium perchlorate) daily. When used for the perchlorate discharge test following administration of the dose of radioiodine tracer, a single dose is given of 30-50 Irenat drops (equivalent to 600-1000 mg sodium perchlorate) or 300 mg-600 mg/m 2 body surface area in children. As pretreatment for radionuclide studies not involving the thyroid itself and using radioactively labelled drugs or antibodies containing iodine or technetium, Irenat drops should be administered at doses of 10 – 20 drops (equivalent to 200-400 mg sodium perchlorate) and, in isolated cases, up to 50 drops (equivalent to 1000 mg sodium perchlorate) so as to reduce exposure of the thyroid to radiation and to block uptake of radionuclide into certain compartments.
    [Show full text]
  • Perchlorates
    Oregon Department of Human Services Office of Environmental Public Health (503) 731-4030 Emergency 800 NE Oregon Street #604 (971) 673-0405 Portland, OR 97232-2162 (971) 673-0457 FAX (971) 673-0372 TTY-Nonvoice TECHNICAL BULLETIN HEALTH EFFECTS INFORMATION Prepared by: ENVIRONMENTAL TOXICOLOGY SECTION March, 2004 PERCHLORATES For More Information Contact: Environmental Toxicology Section (971) 673-0440 Drinking Water Section (971) 673-0405 Technical Bulletin-Health Effects Information Perchlorates Page 2 SYNONYMS Perchlorate Ion, Perchlorate Salts, Perchloric Acid. Examples of perchlorate salts are Sodium Perchlorate, Ammonium Perchlorate, Potassium Perchlorate.Do not confuse with chlorates. USES Perchlorate ion and perchlorate salts are used extensively in industry in the production of military explosives, rocket and missile fuels, fireworks, flares, matches, dyes, lubricants, paints, rubber products and pharmaceuticals. Perchlorates are also used in leather tanning and in electroplating.Perchlorate ion, perchloric acid and perchlorate salts are strong oxidizers, but perchlorate ion has a very high activation temperature, so it can persist in products and in the environment for decades. Perchlorates are natural ingredients in some natural soils and mineral formations.Perchlorate salts are present in some naturally mined nitrate and phosphate fertilizers, particularly rock fertilizers from Chile. Historically perchlorate compounds have had some use as medications in treating persons with overly-active thyroid glands, but this use has
    [Show full text]
  • Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services
    Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services Australian Statistics on Medicines 1997 i © Commonwealth of Australia 1998 ISBN 0 642 36772 8 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be repoduced by any process without written permission from AusInfo. Requests and enquiries concerning reproduction and rights should be directed to the Manager, Legislative Services, AusInfo, GPO Box 1920, Canberra, ACT 2601. Publication approval number 2446 ii FOREWORD The Australian Statistics on Medicines (ASM) is an annual publication produced by the Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee. Comprehensive drug utilisation data are required for a number of purposes including pharmacosurveillance and the targeting and evaluation of quality use of medicines initiatives. It is also needed by regulatory and financing authorities and by the Pharmaceutical Industry. A major aim of the ASM has been to put comprehensive and valid statistics on the Australian use of medicines in the public domain to allow access by all interested parties. Publication of the Australian data facilitates international comparisons of drug utilisation profiles, and encourages international collaboration on drug utilisation research particularly in relation to enhancing the quality use of medicines and health outcomes. The data available in the ASM represent estimates of the aggregate community use (non public hospital) of prescription medicines in Australia. In 1997 the estimated number of prescriptions dispensed through community pharmacies was 179 million prescriptions, a level of increase over 1996 of only 0.4% which was less than the increase in population (1.2%).
    [Show full text]
  • Summary and Recommendations for Thyroid Screening in Pregnancy: Is
    Gregory A. Brent, MD Departments of Medicine and Physiology David Geffen School of Medicine at UCLA Etiologies of Hypothyroidism • Chronic autoimmune thyroiditis-Hashimoto’s disease • Partial thyroidectomy. • Radioactive iodine therapy for treatment of hyperthyroidism. • External radiotherapy of the head and neck in patients with Hodgkin’s lymphoma, leukemia, brain tumors, or bone-marrow transplantation. • Infiltrative disorders of the thyroid gland (eg, amyloidosis, sarcoidosis,hemochromatosis, or Riedel’s thyroiditis). Modified from Cooper and Biondi Lancet 379:1142, 2012 Pearce and Braverman Best Pract Clin Endo Metab 23:801, 2009 Agent Example of Sources Mode of Action Thyroid Disease in Humans Polychlorinated Found in coolants and TR Possible increase in biphenyls (PCBs) lubricants, properties; agonist/antagonist, TSH, thyroid multiple congeners, can alter levels of T4 autoantibodies, thyroid lipophilic and TSH volume Organochlorine Used as pesticide on Induce hepatic No established pesticides crops glucuronyltransferase association (UDPGTs) Polybrominated Found in flame Bind to TRs, Increase in diphenylethers retardants displaces T4 from hypothyroidism in some (PBDEs) binding proteins studies Bisphenol-A (BPA) Used in plastic bottles Antagonize TR, lower No established serum T4 association Adapted from Brent GA Thyroid 20:755, 2010 Agent Example of Mode of Action Thyroid Disease Sources In Humans Perchlorate, Rocket fuel, Inhibits iodine No established Thiocyanate fertilizer, uptake, at sufficient association smoking levels reduces
    [Show full text]
  • 31295018735356.Pdf (3.168Mb)
    AMMONIUM PERCHLORATE-INDUCED LESIONS IN ZEBRAFISH KIDNEYS by TIM CAPPS, B.S. A THESIS IN ENVIRONMENTAL TOXICOLOGY Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE Approved Chairperson of the Committee Accepted Dean of the Graduate School December, 2003 ACKNOWLEDGMENTS 1 would like to especially thank Dr. Reynaldo Patino for being the chairperson of my committee who made this project possible, and for giving me a positive and enjoyable educational experience. 1 would also like to thank the other members of my committee: Dr. Todd Anderson and Professor Victoria Sutton 1 would like to thank Dr. Vickie Blazer for her histological expertise. I would like to thank The Institute of Environmental and Human Health at Texas Tech for giving me monetary support, and being a good organization with great people. I would like to thank the U.S. Geological Survey through the Texas Cooperative Fish and Wildlife Research Unit at Texas Tech, and all of the people there, for the use of facilities and for providing a great work environment. I would also like to thank the U.S. Department of Defense through the Strategic Environmental Research and Development Program, under a cooperative agreement with the US. Air Force Institute for Environmental Safety and Occupational Health, for providing further flinding for this project. Finally, I would like to thank all of my friends, family, and coworkers for their support and understanding. Without all of you this would not have been possible. TABLE OF CONTENTS ACKNOWLEDGMENTS ii ABSTRACT v LIST OF FIGURES vii CHAPTER I.
    [Show full text]
  • Hyper and Hypothyroidism
    Editing File Mnemonic File Endocrine Block Pharmacology team 438 Hyper and Hypothyroidism Objectives: By the end of the lecture , you should know: ● Describe different classes of drugs used in hyperthyroidism and hypothyroidism and their mechanism of action ● Understand their pharmacological effects, clinical uses and adverse effects ● Recognize treatment of special cases such as hyperthyroidism during pregnancy, Graves’ disease and Thyroid Storm and special cases of hypothyroidism such as myxedema coma Color index: Black : Main content Purple: Females’ slides only Red : Important Grey: Extra info or explanation Blue: Males’ slides only Green : Dr. notes Hyperthyroidism Thyroid Function ● Normal amount of thyroid hormones are essential for normal growth and development by maintaining the level of energy metabolism in the tissue. ● Either too little or too much thyroid hormones will bring disorders to the body. Important Functions CVS: increase Growth & Thermoregulation Helps maintain heart rate & development, increase basal metabolic cardiac output especially in the metabolic rate energy balance which increase embryo & brain (BMR) oxygen demand Iodine Importance ● Thyroid hormones are unique biological molecules in that they incorporate iodine1 in their structure ● Adequate iodine intake (diet, water) is required for normal thyroid hormone production ● Major sources of iodine are: iodized salt, iodated bread, dairy products, shellfish ● Minimum requirement: 75 micrograms/day Iodine Metabolism 1 2 3 Iodide taken up by the Dietary iodine
    [Show full text]